Interesting facts
Interesting Facts about 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile
This compound, known for its complexity, belongs to a class of chemicals exhibiting notable biological activities. Here are some captivating insights:
- Structural Richness: The intricate structure features multiple functional groups which contribute to its biological interactions. The presence of dimethoxyphenyl groups suggests potential solubility in organic solvents, broadening its applicability in pharmaceutical formulations.
- Biological Implications: Compounds of this nature often find usage in medicinal chemistry. They can exhibit properties such as antidepressant, anti-inflammatory, or even antitumor activities, making them subjects of extensive research.
- Potential for Modification: The versatility in its structure means that derivatives of this compound can be synthesized to enhance certain desired properties. By tweaking substituents, chemists can optimize efficacy or reduce side effects.
- Research Interest: The ongoing research around such compounds often focuses on understanding their mechanism of action at the molecular level—knowledge that can pave the way for the development of new therapeutic agents.
- Pharmaceutical Development: The pursuit of such complex compounds generally aligns with the pharmaceutical industry’s quest for novel drugs to address unmet medical needs, highlighting the balance between synthetic complexity and functional utility.
As you can see, the study of this compound is not just about its molecular structure, but also its potential impact on health and wellness. The crossroads of chemistry and biology in this context showcases the beauty of scientific exploration.
Synonyms
VERAPAMIL
52-53-9
Iproveratril
Dilacoran
Vasolan
Isoptimo
Verapamilo
Verapamilum
Falicard
Finoptin
Isoptin
Lekoptin
Isoptine
Calan
D-365
Verapamilum [INN-Latin]
Verapamilo [INN-Spanish]
Isotopin
Securon
Calcan
dl-Verapamil
(+/-)-VERAPAMIL
r,s-verapamil
CP-16533-1
Izoptin
Verapamil slow release
CCRIS 6749
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile
5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
Ansyr
EINECS 200-145-1
UNII-CJ0O37KU29
Verelan
Verpamil
CJ0O37KU29
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-
Isoptin SR
Verelan PM
Covera-HS
NSC 272306NA
Calan SR
CP-16,533-1
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
EINECS 260-462-6
alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
Tarka
alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
CP-165331
Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile
CP 16533-1
D 365
DTXSID9041152
CHEBI:77733
HSDB 3928
NSC-272306NA
Anpec
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino) propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-
Verapamil AL
NCGC00016083-09
Verapamilum (INN-Latin)
Verapamilo (INN-Spanish)
5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
Benzeneacetonitrile, .alpha.-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-
(+/-)-Verapamil hydrochlorid
CP-165331 / CP-16533-1
DTXCID7021152
Verapamil [USAN:INN:BAN]
(+/-)-Verapamil;CP-16533-1
CAS-52-53-9
(+/-)-5-((3,4-DIMETHOXYPHENETHYL)METHYLAMINO)-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE
C27H38N2O4
Verapamil (USAN/INN)
DTXSID501009404
Calan (Salt/Mix)
Akilen (Salt/Mix)
MFCD00056240
Verapamilum (Latin)
Isoptin (Salt/Mix)
Cordilox (Salt/Mix)
delta-365
alpha-isopropyl-alpha-
VERAPAMIL [INN]
VERAPAMIL [MI]
Covera-HS (Salt/Mix)
VERAPAMIL [USAN]
Prestwick0_000141
Prestwick1_000141
Prestwick2_000141
Prestwick3_000141
Spectrum2_001740
Spectrum4_000906
Spectrum5_001786
VERAPAMIL [VANDF]
()-Verapamil hydrochlorid
VERAPAMIL [WHO-DD]
CHEMBL6966
Lopac0_001237
SCHEMBL16742
BSPBio_000242
BSPBio_001513
BSPBio_002358
KBioGR_000233
KBioGR_001372
KBioGR_002343
KBioSS_000233
KBioSS_002346
56949-77-0
MLS006011414
DivK1c_000399
SPBio_001820
SPBio_002181
BPBio1_000268
CHEBI:9948
GTPL2406
CP 16533-1 (Verapamil)
SCHEMBL13287282
(A+/-)-Verapamil hydrochloride
BDBM81939
KBio1_000399
KBio2_000233
KBio2_002343
KBio2_002801
KBio2_004911
KBio2_005369
KBio2_007479
KBio3_000465
KBio3_000466
KBio3_002823
C08DA01
()-Verapamil;CP-16533-1
cMAP_000023
NINDS_000399
Bio1_000425
Bio1_000914
Bio1_001403
Bio2_000233
Bio2_000713
HMS1791L15
HMS1989L15
HMS2089H17
HMS3402L15
Tox21_110300
NSC_62969
STK538085
AKOS005468962
Tox21_110300_1
CCG-205311
DB00661
FV02354
SDCCGSBI-0051204.P005
CAS_52-53-9
IDI1_000399
IDI1_033983
NCGC00016083-04
NCGC00016083-05
NCGC00016083-06
NCGC00016083-07
NCGC00016083-08
NCGC00016083-10
NCGC00016083-11
NCGC00016083-13
NCGC00016083-14
NCGC00016083-15
NCGC00016083-16
NCGC00016083-17
NCGC00016083-18
NCGC00016083-20
NCGC00016083-25
NCGC00016083-34
NCGC00024710-04
NCGC00024710-05
NCGC00024710-06
NCGC00024710-07
NCGC00024710-08
NCGC00024710-09
NCGC00344584-01
2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile
AC-16016
BP-21223
HY-14275
NCI60_020143
SMR001550201
SBI-0051204.P003
(-)-3-(3,4-dimethoxyphenyl)-6-[(5,6-dimethoxyphenethyl)methylamino]hexane-3-carbonitrile
DB-349548
AB00053495
CS-0002967
NS00000313
C07188
D02356
E75969
EN300-708774
AB00053495-20
AB00053495_21
L001330
Q410291
BRD-A09533288-001-02-7
BRD-A09533288-003-05-6
BRD-A09533288-003-29-6
BRD-A09533288-003-31-2
F2173-0851
VERAPAMIL, Dexverapamil, Verapamyl hydrochloride, VERAPAMIL HYDROCHLORIDE
.alpha.-((N-Methyl-N-homoveratryl)-.gamma.-aminopropyl)-3,4-dimethoxyphenylacetonitrile
2-(3,4-Dimethoxyphenyl)-5-((2-(3,4-dimethoxyphenyl)ethyl)(methyl)amino)-2-isopropylpentanenitrile, (+/-)-
2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropylpentanenitrile #
200-145-1
alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino) propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile
rac-2-(3,4-dimethoxyphenyl)-5-((2-(3,4-dimethoxyphenyl)ethyl)(methyl)amino)-2-(propan-2-yl)pentanenitrile
Solubility of 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile
The compound with the formula C29H33ClN2O2 presents a unique solubility profile that is influenced by its structural characteristics. Generally, the solubility of a chemical compound can depend on several factors:
In practical terms, it is expected that this compound would show:
As a result, one might observe that "like dissolves like," where organic solvents such as ethanol or acetone are suitable for dissolving this compound effectively. Overall, careful consideration of these factors can guide the appropriate method for preparing solutions of this intriguing compound.